Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

IQVIA Holdings Inc

IQV
204,02
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:07:29
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/11/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202422:15BWIQVIA CFO Ron Bruehlman to Speak at the UBS Global..
31/10/202421:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202412:05EDGAR2Form 8-K - Current report
31/10/202412:00BWIQVIA Reports Third-Quarter 2024 Results and Announces..
15/10/202422:15BWIQVIA to Announce Third-Quarter 2024 Results on October 31,..
02/10/202415:00BWIQVIA Announces IQVIA AI Assistant, Powered by IQVIA..
19/9/202415:00BWIQVIA AI Solution Receives 2024 Frost & Sullivan Global..
04/9/202415:00PRNUSSignant Health expands availability of its eClinical..
29/8/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202423:23EDGAR2Form 144 - Report of proposed sale of securities
21/8/202422:15BWIQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley..
30/7/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/7/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/7/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/7/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/7/202413:05EDGAR2Form 8-K - Current report
22/7/202413:00BWIQVIA Reports Second-Quarter 2024 Results
22/7/202412:06IHMARKETNEWSUS Index Futures Advanced, Oil Prices Inch Higher
11/7/202414:30BWIQVIA Named a Leader in Medical Affairs and Regulatory..
08/7/202422:15BWIQVIA to Announce Second-Quarter 2024 Results on July 22,..
25/6/202414:00BWIQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough..
12/6/202414:00BWIQVIA Launches “One Home” Clinical Trial Technology Platform..
10/6/202414:00BWIQVIA Institute: Innovative Therapies and Strong Pipeline to..
17/5/202423:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202414:00BWU.S. Medicines Spending Grew in 2023 as Greater Access..
10/5/202422:35EDGAR2Form 8-K - Current report
09/5/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:15BWIQVIA CFO Ron Bruehlman to Speak at the Bank of America..
02/5/202413:00BWIQVIA Reports First-Quarter 2024 Results
15/4/202422:15BWIQVIA to Announce First-Quarter 2024 Results on May 2, 2024
08/4/202422:01BWIQVIA and Salesforce Expand Global Partnership to Accelerate..
06/3/202422:15BWIQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global..
02/3/202401:49EDGAR2Form 144 - Report of proposed sale of securities
26/2/202414:00BWIQVIA Publishes its 2023 Environmental, Social and..
23/2/202422:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/2/202415:00BWGlobal Biopharma R&D Boasts Increased Funding, Productivity..
21/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:15BWIQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech..
16/2/202423:20EDGAR2Form 144 - Report of proposed sale of securities
14/2/202413:05EDGAR2Form 8-K - Current report
14/2/202413:00BWIQVIA Reports Fourth-Quarter and Full-Year 2023 Results;..
13/2/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 204,02

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network